Article thumbnail

Dengue in Thailand and Cambodia: An Assessment of the Degree of Underrecognized Disease Burden Based on Reported Cases

By Ole Wichmann, In-Kyu Yoon, Sirenda Vong, Kriengsak Limkittikul, Robert V. Gibbons, Mammen P. Mammen, Sowath Ly, Philippe Buchy, Chukiat Sirivichayakul, Rome Buathong, Rekol Huy, G. William Letson and Arunee Sabchareon


Dengue is a major public health problem especially in tropical and subtropical countries of Asia and Latin-America. An effective dengue vaccine is not yet available, but several vaccine candidates are currently being evaluated in clinical trials. Accurate country-level incidence data are crucial to assess the cost-effectiveness of such vaccines and will assist policy-makers in making vaccine introduction decisions. Existing national surveillance systems are often passive and are designed to monitor trends and to detect disease outbreaks. Our analyses of data from prospectively followed cohorts with laboratory confirmation of dengue cases show that, in Thailand and Cambodia, dengue incidence is underrecognized by more than 8-fold. The magnitude of the outpatient burden caused by dengue is not assessed or reflected by the national surveillance data. We estimate that a median of more than 340,000 symptomatic dengue virus infections occurred annually in children less than 15 years of age in Thailand in Cambodia between 2003 and 2007

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1999). A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996.
  2. (1988). A prospective study of dengue infection in Bangkok.
  3. (2007). Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study.
  4. (2008). Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirusprimed subjects.
  5. (2007). Costeffectiveness of annual targeted larviciding campaigns in Cambodia against the dengue vector Aedes aegypti.
  6. (2004). Dengue and Dengue haemorrhagic fever. In:
  7. (2002). Dengue hemorrhagic fever in Thai society.
  8. (1997). Dengue hemorrhagic fever: Diagnosis, treatment and control. 2 nd edition. Geneva: World Health Organization. Available: csr/resources/publications/dengue/Denguepublication/en.
  9. (2010). Dengue Incidence in Urban and Rural Cambodia: Results from Population-Based Active Fever Surveillance,
  10. (2001). Dengue: An update.
  11. (2009). Disability adjusted life years lost to dengue in Brazil.
  12. (2007). Epidemiology. Annual Epidemiological Surveillance Report
  13. (1997). Hemorrhagic fever in Cambodia is caused by dengue viruses: Evidence for transmission of all four serotypes.
  14. (2003). Improved molecular detection of dengue virus serotype 1 variants.
  15. (2007). Incidence of primary dengue virus infections in Southern Vietnamese children and reactivity against other flaviviruses.
  16. (2008). Kroeger A
  17. (2007). Measuring the Burden of Neglected Tropical Diseases: The Global Burden of Disease Framework.
  18. (2010). Office Thailand () Population and housing census 2000: Key Indicators and important tables from Final Report by Provinces. Available:
  19. (2008). Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naı ¨ve adults.
  20. (1992). Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction.
  21. (1997). Risk factors in dengue shock syndrome.
  22. (2005). Secondary dengue virus type 4 infections in Vietnam.
  23. (2008). Spatial and temporal clustering of dengue virus transmission in Thai villages.
  24. (1999). The Puerto Rico Association of Epidemiologists
  25. (2006). The WHO dengue classification and case definitions: time for a reassessment.
  26. (1998). Using disability-adjusted life years to assess the economic impact of dengue in Puerto Rico: